BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/6/2017 6:30:02 PM | Browse: 1697 | Download: 2275
 |
Received |
|
2017-01-20 10:05 |
|
Peer-Review Started |
|
2017-01-22 13:14 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-02-13 13:00 |
|
Revised |
|
2017-02-24 00:09 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-03-09 13:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-03-15 09:59 |
|
Articles in Press |
|
2017-03-15 09:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-03-28 09:17 |
|
Publish the Manuscript Online |
|
2017-04-06 18:30 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lorenza Rimassa, Maria Reig, Giovanni Abbadessa, Markus Peck-Radosavljevic, William Harris, Vittorina Zagonel, Davide Pastorelli, Elena Rota Caremoli, Camillo Porta, Nevena Damjanov, Hitendra Patel, Bruno Daniele, Maria Lamar, Brian Schwartz, Terri Goldberg, Armando Santoro and Jordi Bruix |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Lorenza Rimassa, Deputy Director, Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, 20089 Rozzano, Italy. lorenza.rimassa@cancercenter.humanitas.it |
| Key Words |
Liver neoplasms; Biopsy; Biomarkers; Clinical trial; Tumor |
| Core Tip |
Despite the extensive research conducted in the last two decades, still only two agents have shown positive results in phase III clinical trials for advanced hepatocellular carcinoma, and clinicians have no way to predict which patient population will benefit more. Biomarker research and well-run clinical trials require biopsies and a multidisciplinary approach to manage patients with hepatocellular carcinoma. |
| Publish Date |
2017-04-06 18:30 |
| Citation |
Rimassa L, Reig M, Abbadessa G, Peck-Radosavljevic M, Harris W, Zagonel V, Pastorelli D, Rota Caremoli E, Porta C, Damjanov N, Patel H, Daniele B, Lamar M, Schwartz B, Goldberg T, Santoro A, Bruix J. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(13): 2448-2452
|
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i13/2448.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i13.2448 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
